Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    "Myxoid liposarcoma"
Show Display Options
Rank Status Study
1 Unknown  Brostallicin Clinical Trial for Myxoid Liposarcoma
Condition: Myxoid Liposarcoma
Intervention: Drug: Brostallicin
2 Recruiting Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas
Condition: Myxoid Liposarcoma of Soft Tissue
Intervention: Radiation: dose reduction of preoperative radiotherapy in MLS
3 Recruiting Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma
Conditions: Conventional Chondrosarcoma;   Myxoid Liposarcoma;   Mesenchymal Chondrosarcoma;   Dedifferentiated Chondrosarcoma
Intervention: Drug: sirolimus and cyclophosphamide
4 Recruiting Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery
Condition: Liposarcoma
Intervention: Drug: efatutazone
5 Recruiting Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma
Conditions: Myxoid Liposarcoma;   Round Cell Liposarcoma;   Synovial Sarcoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Recombinant Interferon Gamma
6 Withdrawn NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Conditions: Adult Synovial Sarcoma;   Myxoid/Round Cell Liposarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage IV Adult Soft Tissue Sarcoma
Interventions: Biological: Autologous NY-ESO-1-specific CD8-positive T Lymphocytes;   Drug: Cyclophosphamide;   Other: Laboratory Biomarker Analysis
7 Completed
Has Results
Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma
Condition: Liposarcoma,Myxoid
Interventions: Drug: Trabectedin;   Drug: Dexamethasone
8 Completed Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery
Conditions: Adult Liposarcoma;   Adult Synovial Sarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage IV Adult Soft Tissue Sarcoma
Interventions: Drug: cyclophosphamide;   Biological: NY-ESO-1-specific T cells;   Other: laboratory biomarker analysis
9 Recruiting Trial of CMB305 and Atezolizumab in Patients With Sarcoma
Conditions: Sarcoma;   Myxoid/Round Cell Liposarcoma;   Synovial Sarcoma;   Metastatic Sarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Locally Advanced Sarcoma;   Liposarcoma
Interventions: Biological: CMB305;   Biological: atezolizumab

Study has passed its completion date and status has not been verified in more than two years.